High-Dimensional Cytometry Uncovers Platelets’ Role in Immunity and Inflammation – ASH
ASH has shared the following update on its X page:
“Platelets do more than hemostasis! High-dimensional cytometry shows their roles in immune responses, inflammation, and thrombosis. Learn how these advances link genetic variants to bleeding disorders.”
Platelets in a New Light: Insights from High-Dimensional Cytometry
Recent advances in high-dimensional cytometry are reshaping our understanding of platelet biology, revealing roles that go far beyond hemostasis. Emerging evidence shows that platelets are not merely passive participants in clot formation but active regulators in:
Immune response modulation
Inflammatory signaling pathways
Thrombotic processes linked to vascular injury
Interplay with genetic variants in bleeding and clotting disorders
These technologies allow for detailed phenotypic profiling of platelet subsets, offering new perspectives in diagnosing and managing immune-mediated thrombocytopenia, inherited platelet function defects, and inflammatory thrombotic conditions.
Title: Technology Spotlight
New Dimensions for Platelet Evaluation in Hematology Diagnostics
Authors: Sean X. Gu, MD, PhD, Robert D. Bona, MD, John Hwa, MD, PhD
Read the full article.
For more expert-driven insights, visit Hemostasis Today – your trusted resource for cutting-edge developments in thrombosis and hemostasis.
-
Aug 16, 2025, 14:00Iron Deficiency in Polycythemia Vera: William Aird Reveals JAK2-Driven Erythropoiesis as The Key Cause
-
Aug 15, 2025, 23:36Irene M Lang's Editorial on Getting Risk Assessment Right in Acute Pulmonary Embolism
-
Aug 15, 2025, 23:31Richard Buka: Many Improvements Needed in HIT Management
-
Aug 15, 2025, 23:29Cathy Harrison: Launching A Journal Club from EAHAD and WFH
-
Aug 15, 2025, 23:24PERT 2025 Symposium Session XIII: Expert Insights on CTEPH Diagnosis, Surgery and BPA Innovations - Join the Conversation
-
Aug 16, 2025, 13:42LMWH Use for VTE Prophylaxis in COVID-19 Hospitalized Patients - Multicenter Data from China
-
Aug 15, 2025, 23:35SEC61B Mediated Platelet Hyperactivity in People with Diabetes
-
Aug 15, 2025, 23:32Fibrinogen Concentrate Safely Replaces Cryoprecipitate in Neonatal Cardiac Surgery
-
Aug 15, 2025, 23:31Marc Carrier: Low Awareness of Cancer-Associated Thrombosis Among Canadians
-
Aug 15, 2025, 23:28Michael Makris Questions FVIII Aurora’s Potential to Transform Hemophilia A Gene Therapy
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman